Dexcom G5 Mobile Continuous Glucose Monitoring System Receives CE Mark

Dexcom, a leader in continuous glucose monitoring (CGM) for patients with diabetes, has received CE Mark (Conformite Europeenne) for its Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System.

The new system is the first mobile-connected CGM in the EU and is recommended for adults and children as young as two years of age.

GlySure Clears European Regulatory Approval For Novel Glucose Monitoring System
The device can be used for close monitoring of blood glucose levels in critically ill patients every 15 seconds through an automated calibration module.

The device offers wireless Bluetooth technology housed in the device transmitter. The technology allows glucose information to be displayed directly onto a smart phone freeing users from the need to carry a separate receiver for greater convenience and discretion.

Users can still use the System Receiver as an alternate display if they so choose. The system also lets users select up to five designated recipients, or ‘followers’ who can remotely monitor the patient's glucose information and receive alert notifications from almost anywhere for an added circle of support.

In addition, the system does not require confirmatory finger sticks when making treatment decisions. The added convenience and cost savings associated with no longer performing finger sticks to verify readings on the CGM will greatly enhance the appeal of this integrated diabetes management system . The new device approved for use without confirmatory finger sticks will initially only be made available outside of the United States.

24-7 Glucose Monitoring may Help Manage Diabetes
Due to dropping or spiking of blood sugar levels associated with diabetes, nearly half a million people with diabetes end up in emergency rooms around the U.S. every year

"The Dexcom G5 Mobile CGM System lets users see and treat their diabetes in a whole new way - right on a smart device and without the need to perform confirmatory finger sticks for treatment decisions - it's dynamic glucose information when you want it and where you want it. With an enhanced interface and fully mobile design, the device is changing the landscape of diabetes management, offering users greater convenience, flexibility and discretion than ever before," said Kevin Sayer, President and Chief Executive Officer of Dexcom.

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System
Animas Corporation has announced Food and Drug Administration (FDA) approval of the Animas Vibe insulin pump and Continuous Glucose Monitoring (CGM) system.

Source-Medindia

Personal Glucose Monitors to Detect DNA
At-home glucose meter can be adapted to a home DNA detector that enables individuals to detect home tests for virus and bacteria in human body fluids, reveals study.